文件名称：Human Brain Proteome
文件大小：8.52MB
文件格式：PDF
更新时间：2012-07-08 16:01:05
Human Brain Proteome
I. Introduction........................................................................ 3 II. Transcriptomics.................................................................... 4 III. Proteomics Methodologies for Biomarker Discovery......................... 7 IV. Principles of SELDI-TOF-MS..................................................... 12 V. SELDI-TOF-MS in Clinical Proteomics Research............................. 17 VI. Biomarkers in Specific Diseases................................................. 18 VII. Metabolomics....................................................................... 25 VIII. Conclusions......................................................................... 26 References.......................................................................... 27 Proteomic Analysis of Mitochondrial Proteins Mary F. Lopez,Simon Melov,Felicity Johnson, Nicole Nagulko,Eva Golenko,Scott Kuzdzal, Suzanne Ackloo, and Alvydas Mikulskis I. Introduction........................................................................ 31 II. Model Systems...................................................................... 32 III. Technological Approaches....................................................... 33 IV. Differential Expression of Proteins in Mouse Brain Mitochondria from Cortex and Synaptosomes........................................................ 38 V. Conclusions......................................................................... 43 References.......................................................................... 44 v vi CONTENTS SECTION II PROTEOMIC APPLICATIONS NMDA Receptors, Neural Pathways, and Protein Interaction Databases Holger Husi I. Introduction ........................................................................ 51 II. NMDA Receptor.................................................................... 52 III. Molecular Clustering .............................................................. 55 IV. Signal Transduction Pathways.................................................... 61 V. Bioinformatic Analysis............................................................. 63 VI. Proteomic Databases............................................................... 67 VII. Future Directions .................................................................. 73 References........................................................................... 74 Dopamine Transporter Network and Pathways Rajani Maiya and R. Dayne Mayfield I. Introduction ........................................................................ 79 II. Structure and Function of DAT ................................................. 80 III. Cellular Localization of DAT..................................................... 81 IV. Regulation of DAT................................................................. 81 V. Mass Spectrometry-Based Proteomics........................................... 83 VI. Isolation and Validation of the DAT Proteome............................... 84 VII. Mass Spectrometry................................................................. 85 VIII. Confirmation of Members of the DAT Proteome............................. 85 IX. In Silico Analysis of DAT Proteome.............................................. 90 References........................................................................... 93 Proteomic Approaches in Drug Discovery and Development Holly D. Soares,Stephen A. Williams,Peter J. Snyder,Feng Gao, Tom Stiger,Christian Rohlff,Athula Herath,Trey Sunderland, Karen Putnam, and W. Frost White I. Proteomics in Drug Discovery and Development............................. 97 II. Using Proteomics to Identify Biomarkers of Alzheimer’s Disease: A Case Study........................................................................ 104 III. Future Challenges and Conclusions............................................. 120 References........................................................................... 121 CONTENTS vii SECTION III INFORMATICS Proteomic Informatics Steven A. Russell,William Old,Katheryn A. Resing, and Lawrence Hunter I. What is Proteomics?............................................................... 129 II. Proteomic Informatics............................................................ 131 III. Mass Spectrometry and Shotgun Proteomics.................................. 131 IV. Identifying Proteins ............................................................... 134 V. Post-hoc Validation of Protein Identification Program Output............ 139 VI. Quantification...................................................................... 141 VII. Detection of Protein Isoforms................................................... 142 VIII. Systems and Workflow Issues .................................................... 146 IX. Conclusion.......................................................................... 150 X. Appendix: List of Mentioned Algorithms by Topic.......................... 150 References.......................................................................... 154 SECTION IV CHANGES IN THE PROTEOME BY DISEASE Proteomics Analysis in Alzheimer’s Disease: New Insights into Mechanisms of Neurodegeneration D. Allan Butterfield and Debra Boyd-Kimball I. Introduction........................................................................ 161 II. Proteomics Tools .................................................................. 162 III. Proteomic Studies in AD......................................................... 170 IV. Proteomics Analysis of Transgenic Models of AD............................ 181 V. Future of Proteomics in AD ..................................................... 182 References.......................................................................... 182 Proteomics and Alcoholism Frank A. Witzmann and Wendy N. Strother I. Introduction........................................................................ 189 II. Proteomics of the Hippocampus and Nucleus Accumbens................. 192 III. Future Directions.................................................................. 203 IV. Conclusion.......................................................................... 211 References.......................................................................... 211 viii CONTENTS Proteomics Studies of Traumatic Brain Injury Kevin K. W. Wang,Andrew Ottens,William Haskins,Ming Cheng Liu, Firas Kobeissy,Nancy Denslow,SuShing Chen, and Ronald L. Hayes I. Introduction ........................................................................ 215 II. Traumatic Brain Injury............................................................ 216 III. Proteomics Analysis Overview.................................................... 221 IV. Protein Separation Methods...................................................... 221 V. Protein Identification and Quantification Methods.......................... 225 VI. TBI Proteomics Bioinformatics .................................................. 232 VII. Prospective Utilities of TBI Proteomics Data.................................. 237 References........................................................................... 237 Influence of Huntington’s Disease on the Human and Mouse Proteome Claus Zabel and Joachim Klose I. Introduction ........................................................................ 241 II. Neurodegenerative Disorders Caused by Elongated Poly-Glutamine Repeats .............................................................................. 242 III. Approach for an HD Proteomics Study ........................................ 248 IV. Materials and Methods............................................................ 248 V. Proteomics Study of HD .......................................................... 249 VI. Discussion........................................................................... 270 VII. Conclusion.......................................................................... 277 References........................................................................... 278 SECTION V OVERVIEW OF THE NEUROPROTEOME Proteomics—Application to the Brain Katrin Marcus,Oliver Schmidt,Heike Schaefer, Michael Hamacher,AndrO van Hall, and Helmut E. Meyer I. Introduction ........................................................................ 287 II. Potential of Proteomics ........................................................... 288 III. Methods in Proteome Analysis................................................... 289 IV. Proteome Analysis in Neurosciences............................................ 299 V. Administrative Realization of Neuroproteomics............................... 303 References........................................................................... 307 Index........................................................................................ 313 Contents of Recent Volumes..................................................... 325